中国抗体-B(03681)完成发行1.13亿股认购股份

智通财经
29 May

智通财经APP讯,中国抗体-B(03681)发布公告,由于各份认购协议所载先决条件已获达成,认购事项已根据各认购协议的条款及条件于2025年5月29日完成。合共1.13亿股股份,相当于公司经发行认购股份扩大的已发行股本约9.37%,已按每股认购股份港币1.10元的认购价发行予认购人。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10